Strategic Partnerships Growth Capitalize on the recent alliance with Synexis to offer a combined biosafety and disinfection solution to US life sciences customers. Position Quip as a one-stop provider for hygiene, safety, and advanced surface decontamination, enabling labs to simplify procurement. Target mid-sized labs, CROs, and academic facilities that require reliable, scalable biosafety programs and want integrated DHP technology.

Disinfection Portfolio Expansion Leverage the Halosil acquisition and ongoing DHP collaboration to upsell enhanced disinfection capabilities. Create bundled offerings that pair Quip's biosafety management services with proven disinfection products for critical areas such as clean rooms and gnotobiotic facilities. Develop case studies and ROI-focused pitches showing reduced risk and simplified compliance.

Education Driven Sales Promote Biosafety University tools as value added sales enablers. Offer training modules, dilution calculators, and chemical formulas as paid or premium content to help labs optimize safety workflows. Use the platform to capture leads, upsell advanced training, and drive ongoing engagement with decision makers.

Vertical Channel Leverage Utilize exclusive distribution arrangements like MB-10 tablets in transportation vertical to reach adjacent markets with biohazard cleaning needs. Explore expansion into other verticals through existing distribution channels and partnerships, offering Quip's biosafety and disinfection solutions alongside logistical and facility management solutions.

Subject Matter Focus Highlight team expertise in gnotobiotics and biosafety consulting to win niche accounts such as specialized research facilities and universities. Leverage key personnel to tailor solutions, conduct technical demonstrations, and build trust with lab directors and facility managers. Align messaging with the growing emphasis on robust biosafety programs and lab hygiene.